A.P. Pharma

Absorption Pharmaceuticals is the manufacturer of PROMESCENT. The strict topic guidance treatment approved by the U.S. Food and Drug Administration (FDA) was developed by Dr. Ronald Gilbert, a urologist, founder, and Chief Medical Officer of Absorption Pharmaceuticals. The lidocaine-based topical anesthetic employs advanced patented transdermal absorption technology. Since its official launch in 2011, PROMESCENT has been warmly welcomed by top experts in the fields of sexual medicine and urology worldwide.